Provide Pre-approval Expanded Access of LY3437943

Sponsor
Eli Lilly and Company
Study ID
NCT07629401
Status
Available

Eligibility Criteria

Sex
All
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Provide pre-approval single patient expanded access of retatrutide for patients.

Key Dates

Status verified
Jun 2026

Central Contacts

  • The Lilly Answers Center
    1-800-LillyRx (1-800-545-5979)